Biotecnologia – Portugal

Workshop Antiparasitic and Antitumor drugs 12/07/2011

Filed under: Biotecnologia,Eventos — Hugo Azevedo @ 14:44

8 and 9 of September 2011 at IBMC, Porto, Portugal

Host Institutions: I3S

  
 
Deadlines for abstract submission 15 July | Registrations until 31 July
 
  
  
 

PROGRAMME:

DAY 1: Anti-trypanosomatid drugs: from the clinic to therapeutic targets and drugs

9.00 Welcome

9.20 Leishmaniasis: Clinical manifestations, therapy and threat of drug resistance
Sarman Singh, Rajendra Memorial Research Institute of Medical Sciences, Agamkuan, Patna, India

10.00 New insights on leishmaniasis in immunosuppressive conditions
Javier Moreno, Instituto de Salud Carlos III, Spain

10.40 – 11.10 Coffee break

11.10 In silico approaches to target drug discovery
Nilanjan Roy, National Institute of Pharmaceutical Education and Research, India

11.50 A rational approach for drug targeting with special reference to Leishmania SIR2
Ali Ouaissi, INSERM, Montpellier, France

12.30 – 14.30 Lunch break and poster session I

14.30 The discovery of thiadiaza derivatives as pteridine reductase inhibitors in combinations with pyrimetamine as drugs against Leishmania parasites
Maria Paola Costi, Universita Degli Studi di Modena e Reggio Emilia, Italy

15.10 Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani in Bihar
Pradeep Das, Rajendra Memorial Research Institute Of Medical Sciences. Agam Kuan, Patna, India

15.50-17.20 Coffee break and poster session I (Antiparasitic drugs)

17.20 Hypusine bisynthetic pathway as a novel drug target in L. donovani
R. Madhubala, School of Life Sciences, Jawaharlal Nehru University, New Delhi

18.00 End of the day

18.15 ERA–Net Meeting

DAY 2: Antitumour drugs: from molecular target validation to novel drugs

9.00 Towards new medicines or myths? – The importance of biological target validation in drug discovery
David Haigh, Centre for Cancer Research & Cell Biology, Queen’s University Belfast, UK

9.40 Targeting PI3K/mTOR cell signaling pathway in cancer
Carlos Garcia-Echeverria, Sanofi Aventis, France

10.20 –10.50 Coffee break

10.50 Targeting angiogenesis in cancer
Raquel Soares, FMUP, Portugal

11.30 Classical tumour resistance in the molecular age
Robert O’Connor, NICB, Dublin, Ireland

12.10 – 14.10 Lunch break

14.10 Polyamine derivatives: synthesis and their use in parasitic and cancer diseases?
Paul kong Thoo Lin, Robert Gordon University, Aberdeen, UK

14.50 Selected oral communications I (Antiparasitic drugs) (3x20min)

15.50-17.20 Coffee break and poster session II (Antitumour drugs)

17.20 Selected oral communications II (Antitumour drugs) (3x20min)

18.20 Adjourn

 Official Website

 

Deixe uma Resposta

Preencha os seus detalhes abaixo ou clique num ícone para iniciar sessão:

Logótipo da WordPress.com

Está a comentar usando a sua conta WordPress.com Terminar Sessão / Alterar )

Imagem do Twitter

Está a comentar usando a sua conta Twitter Terminar Sessão / Alterar )

Facebook photo

Está a comentar usando a sua conta Facebook Terminar Sessão / Alterar )

Google+ photo

Está a comentar usando a sua conta Google+ Terminar Sessão / Alterar )

Connecting to %s